Clinical studies have demonstrated that GLP-1 receptor agonists can reduce various inflammatory biomarkers , including: C-reactive protein (CRP) : A general marker of systemic inflammation Interleukin-6 (IL-6) : A pro-inflammatory cytokine Tumour necrosis factor-alpha (TNF-) : Another key inflammatory mediator Plasminogen activator inhibitor-1 (PAI-1) : Associated with cardiovascular inflammation The magnitude of these effects varies between studies and may depend on baseline inflammatory status, degree of weight loss achieved, and individual patient characteristics
Mod Razif MRF, Chan SY, Chew Y-L, Hassan M, Ahmad Hisham S, Abdul Rahman S et al (2024) Recent developments in luteolin-loaded nanoformulations for enhanced anti-carcinogenic activities: insights from in vitro and in vivo studies
This effect eventually causes the attenuation of cancer cell proliferation and death
Under certain conditions, the demand for L-carnitine may exceed an individual's capacity to synthesize it, making it a conditionally essential nutrient (3, 4)
Dietary modificationsincreased fiber intake, adequate hydration, and smaller frequent mealssupport gut adaptation
is recipient of the 2017 Global ASPIRE Young Investigator Research Awards in Endocrinology supported by Pfizer, Inc
